Pharmacokinetics of enoxaparin in COVID-19 critically ill patients-Reference-Cited by-同舟云学术

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients

Published:2021-09 Issue: Volume:205 Page:120-127
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Zufferey Paul Jacques,Dupont Annabelle,Lanoiselée Julien,Bauters Anne,Poissy Julien,Goutay Julien,Jean Laurent,Caplan Morgan,Levy Lionel,Susen Sophie,Delavenne Xavier

Publisher

Elsevier BV

Subject

Hematology

Reference49 articles.

1. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis;Nopp;Res. Pract. Thromb. Haemost.,2020

2. CRICS TRIGGERSEP group (Clinical research in intensive care and sepsis trial Group for Global Evaluation and Research in Sepsis), high risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study;Helms;Intensive Care Med.,2020

3. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients;Schünemann;Blood Adv.,2018

4. ESA VTE guidelines task force, european guidelines on perioperative venous thromboembolism prophylaxis: intensive care;Duranteau;Eur. J. Anaesthesiol.,2018

5. GIHP and GFHT, prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring;Susen;Crit. Care Lond. Engl.,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia;Therapeutics and Clinical Risk Management;2024-09

2. Anti-Xa activity below range is related to thrombosis in patients with severe COVID-19;Medicina Intensiva (English Edition);2024-07

3. Impact of augmented renal clearance on anticoagulant therapy in critically ill patients with coronavirus disease 2019: A retrospective cohort study;Journal of Infection and Chemotherapy;2024-02

4. Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19;Clinical Pharmacokinetics;2023-04-25

5. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care;European Journal of Anaesthesiology;2023-04